Preclinical and clinical studies on the use of growth factors for bone repair: A systematic review

Current Stem Cell Research and Therapy

Volumn 8, Issue 3, 2013, Pages 260-268

  Fisher, Daniel Mark ^a   Wong, James Min Leong ^a   Crowley, Conor ^a   Khan, Wasim S ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone morphogenic proteins; Bone repair; Growth factors

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT GROWTH FACTOR; RECOMBINANT OSTEOGENIC PROTEIN 1; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEFECT; BONE GRAFT; BONE MATRIX; BONE REMODELING; BONE TRANSPLANTATION; COMPRESSION PLATE; DEBRIDEMENT; DISTRACTION OSTEOGENESIS; FRACTURE; FRACTURE EXTERNAL FIXATION; FRACTURE HEALING; HUMAN; IN VIVO STUDY; INTRAMEDULLARY NAIL; INTRAMEDULLARY NAILING; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOSYNTHESIS; PRIORITY JOURNAL; PSEUDARTHROSIS; SYSTEMATIC REVIEW; THROMBOCYTE RICH PLASMA; TIBIA OSTEOTOMY; TISSUE ENGINEERING; WEIGHT BEARING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CLINICAL TRIALS AS TOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING; WOUND HEALING;

EID: 84876701150     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308030011     Document Type: Article

References (52)

1. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998; 355 Suppl: S7-21.
2. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 2002; 84-A: 454-64.
3. De Long WG, Einhorn TA, Koval K, et al. Bone Grafts and Bone Graft Substitutes in Orthopaedic Trauma Surgery. A Critical Analysis. J Bone Joint Surg Am 2007; 89: 649-58.
4. Neman J, Hambrecht A, Cadry C, Jandial R. Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering. Biologics 2012; 6: 47-57.
5. Urist MR. Bone: Formation by autoinduction. Science 1965; 150: 893-9.
6. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-34.
7. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 1999; 22(7): 669-71.
8. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 2001; 83: S151-8.
9. Perry CR, Cole D, Perry M, Cierny G. Osteogenic protein (OP-1) vs autograft in the management of tibial nonunions. Proceedings of the 13th Annual Meeting of the Orthopaedic Trauma Association; 1997 Oct 17-19; Louisville www.hwbf.org/ota/am/ota97/otapo/OTP97064.htm
10. Calori GM, Tagliabue L, Gala L, d'Imporzano M, Peretti G, Albisetti W. Application of rhBMP7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. Injury 2008; 39(12): 1391-402.
11. Bilic R, Simic P, Jelic M, et al.Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. International Orthopaedics 2006; 30(2): 128-34.
12. Bong MR, Capla EL, Egol KA, et al. Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions. Bulletin Hosp Joint Dis 2005; 63: 20-3.
13. Dimitriou R, Dahabreh Z, Katsoulis E, et al. Application of recombinant BMP-7 on persistent upper and lower limb nonunions. Injury 2005; 36(Suppl 4): S51-9.
14. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999; 81(4): 710-8.
15. Ekrol I, Hajducka C, Court-Brown C, McQueen MM. A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. Injury 2008; 39(Suppl 2): S73-82.
16. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled. Randomized study of four hundred and fifty patients. J Bone Joint Surg 2002; 84: 2123-34.
17. McKee MD, Schemitsch EH, Waddell JP, et al. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial. Proceedings of the 18th Annual Meeting of the Orthopaedic Trauma Association; 2002 Oct 11-13; Toronto www.hwbf.org/ota/am/ota02/otapa.
18. Aro HT, Govender S, Patel AD, et al. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am 2011; 93(9): 801-8.
19. Maniscalco P, Gambera D, Bertone C, Rivera F, Crainz E, Urgelli S. Healing of fresh tibial fractures with OP-1. A preliminary report. Acta Bio-Medica de l Ateneo Parmense 2002; 73(1-2): 27-33.
20. Mckee MD, Waddell JP, Wild L. The treatment of long bone nonunion with rh BMP: results of a prospective pilot study. 71st AAOS meeting, March 10-14, 2004.
21. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 2006; 88(7): 1431-41.
22. Schwartz ND, Hicks BM. Segmental bone defects treated using recombinant human bone morphogenetic protein. J Orthopaedics 2006; 3(2):e2.
23. Calori GM, D'Avino M, Tagliabue L, Albisetti W, d'Imporzano M, Peretti G. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 2006; 37(Suppl 3): S43-50.
24. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994; 15(2): 203-8.
25. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, Guldberg RE. Combination of platelet-rich plasma with polycaprolactonetricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A 2007; 81(4): 888-99.
26. Kasten P, Vogel J, Geiger F, et al. The effect of platelet rich plasma on healing in critical-size long-bone defects. Biomaterials 2008; 29: 3983-92.
27. Ranly DM, McMillan J, Keller T, et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am 2005; 87(9): 2052-64.
28. Ranly DM, Lohmann CH, Andreacchio D, Boyan BD, Schwartz Z. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 2007; 89(1): 139-47.
29. Sarkar MR, Augat P, Shefelbine SJ, et al. Bone formation in a long bone defect model using a platelet-rich plasma loaded collagen scaffold. Biomaterials 2006; 27: 1817-23.
30. Bibbo C, Bono CM, Lin SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv 2005; 14(1): 17-22.
31. Dallari D, Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 2007; 89(11): 2413-20.
32. Savarino L, Cenni E, Tarabusi C, et al. Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 2006; 76(2): 364-72.
33. Shekkeris AS, Jaiswal PK, Khan WS. Clinical applications of mesenchymal stem cells in the treatment of fracture non-union and bone defects. Curr Stem Cell Res Ther 2012; 7(2): 127-33.
34. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2(6): 477-88.
35. Khan WS, Adesida AB, Hardingham TE. Hypoxic Conditions Increase HIF2a and Enhance Chondrogenesis in Stem Cells from the Infrapatellar Fat Pad of Osteoarthritic Patients. Arthritis Res Ther 2007; 9(3): R55.
36. Undale AH, Westendorf JJ, Yaszmeski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc 2009; 84(10): 893-902.
37. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-71.
38. Karsenty G and Wagner EF Reaching a Genetic and Molecular Review Understanding of Skeletal Development. Developmental Cell 2002; 2: 389-406.
39. Coutu DL, Francois M, Galipeau J. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 2011; 117/25: 6801-12.
40. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295-312.
41. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow-derived mesenchymal stem cells regenerate a critical sized segmental bone defect. Tissue Eng 1997; 3(2): 173-85.
42. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997; 12: 1606-14.
43. Lisignoli G, Zini N, Remiddi G, et al. Basic fibroblast growth factor enhances in vitro mineralization of rat bon marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffold. Biomaterials 2001; 22: 2095-105.
44. Lisignoli G, Fini M, Giavaresi G, Nicoli AN, Toneguzzi S, Facchini A. Osteogenesis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials 2002; 23(4): 1043-51.
45. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 2004; 10(5-6): 955-64.
46. Hou R, Chen F, Yang Y, et al. Comparative study between coral mesenchymal stem Cells rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model. Journal of Biomedical Materials Research Part A 2006; 5: 87-99.
47. Gamradt SC, Abe N, Bahamonde ME, et al. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clin Orthop 2006; 450: 238-45.
48. Chang SC, Wei FC, Chuang H, et al. Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast Reconstr Surg 2003; 112: 1841-50.
49. Lin L, Shen Q, Wei X, et al. Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects. Calcif Tissue Int 2009; 85: 55-65.
50. Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Distraction osteogenesis of the lower extremity in patients with achondroplasia/ hypochondroplasia treated with transplantation of cultureexpanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop 2007; 27: 629-34.
51. Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004; 364: 766-70.
52. Mesimäki K, Lindroos B, Törnwall J, et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxill Surg 2009; 38(3): 201-9.